Teva (TEVA) Beats on Q2 Earnings, Misses Sales, Shares Dip

Teva’s second-quarter earnings came in at 78 cents per share which beat consensus estimate of 67 cents. Teva posted revenues of $4.70 billion, which missed consensus estimates of $4.76 billion. Sales declined 18%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.